Clinical Trials

    Showing 1 - 2 of 2 Kidney Transplant

    A Double-blind, Randomized, Controlled Dose Escalation Trial of Autologous Mesenchymal Stromal Cells in Living Donor Kidney Transplant Recipients

    Status: Enrolling

    Investigator: Ahmed Gaber

    Study Coordinator:

    Phone:

    Kidney transplantation is a good treatment option for people with kidney disease. However, there is still much to learn about how to best care for the transplanted kidney and keep it functioning for a long time. Transplant recipients receive inductio... Read more >

    A Phase 2, Randomized, Placebo-Controlled Study to Evaluate Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

    Status: Enrolling

    Investigator: Ahmed Gaber

    Study Coordinator: Jack Curtis

    Phone: 913.486.9249

    This is a randomized, double-blind, placebo-controlled trial in de novo kidney transplant patients to determine if the addition of fingolimod (brand name Gilenya®, candidate name- FTY720) on the background of standard immunosuppression will prevent e... Read more >